These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3321555)

  • 1. A positive B cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft.
    Taylor CJ; Chapman JR; Fuggle SV; Ting A; Morris PJ
    Tissue Antigens; 1987 Sep; 30(3):104-12. PubMed ID: 3321555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome.
    Taylor CJ; Chapman JR; Ting A; Morris PJ
    Transplantation; 1989 Dec; 48(6):953-8. PubMed ID: 2595783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of class I and class II HLA antigens in cadaveric renal transplantation.
    Sengar DP; Couture RA; Raman S; Jindal SL; Lazarovits AI
    Transplant Proc; 1987 Aug; 19(4):3422-5. PubMed ID: 3303509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome.
    Chapman JR; Taylor CJ; Ting A; Morris PJ
    Transplantation; 1986 Dec; 42(6):608-13. PubMed ID: 3538548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.
    Willicombe M; Brookes P; Sergeant R; Santos-Nunez E; Steggar C; Galliford J; McLean A; Cook TH; Cairns T; Roufosse C; Taube D
    Transplantation; 2012 Jul; 94(2):172-7. PubMed ID: 22735711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HLA class II alloantigen detected by an alloantiserum TK2.
    Matsuki K; Juji T; Satake M
    Hum Immunol; 1987 Mar; 18(3):247-56. PubMed ID: 3494716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and significance of donor-reactive B cell antibodies in current sera of kidney transplant patients.
    Karuppan SS; Lindholm A; Möller E
    Transplantation; 1990 Mar; 49(3):510-5. PubMed ID: 2316012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of a positive crossmatch in liver transplantation.
    Karuppan S; Ericzon BG; Möller E
    Transpl Int; 1991 Apr; 4(1):18-25. PubMed ID: 1711853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation.
    Omrani O; Alawwami M; Buraiki J; Selimovic N
    Ann Saudi Med; 2018; 38(2):97-104. PubMed ID: 29620542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method for determining anti-B cell antibodies and their specificity using flow cytometry.
    Berteli AJ; Daniel V; Terness P; Opelz G
    J Immunol Methods; 1993 Aug; 164(1):21-5. PubMed ID: 8360506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?
    Carta P; Di Maria L; Caroti L; Buti E; Antognoli G; Minetti EE
    Transplant Rev (Orlando); 2015 Jul; 29(3):135-8. PubMed ID: 25976621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.